The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Białas, Adam Jerzy ^a   Sitarek, Przemysław ^a   Miłkowska Dymanowska, Joanna ^a   Piotrowski, Wojciech Jerzy ^a   Górski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; ELECTRON TRANSPORT PROPERTIES;

ANTIOXIDANT DEFENCE; ANTIOXIDATIVE; CARBONYL STRESS; CHRONIC INFLAMMATORY; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CIGARETTE SMOKES; ELECTRON TRANSPORT CHAIN; PHYSIOLOGICAL FUNCTIONING;

PULMONARY DISEASES;

ANTIOXIDANT; CARBONYL DERIVATIVE; REACTIVE OXYGEN METABOLITE; OXIDIZING AGENT;

CELL STRESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; HUMAN; IMMUNOCOMPETENT CELL; LUNG PARENCHYMA; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN CARBONYLATION; SMOKING;

DISEASES; PATHOLOGY;

ANTIOXIDANTS; HUMANS; LUNG; MITOCHONDRIA; OXIDANTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES; SMOKING;

EID: 85009446627     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/7808576     Document Type: Review

References (216)

1. Global Initiative for Chronic Obstructive Pulmonary Disease, "Global Strategy for the diagnosis, management, prevention of Chronic Obstructive Pulmonary Disease, " http://goldcopd . org/global-strategy-diagnosis-management-prevention-copd-2016/.
2. Burden of COPD, "Chronic respiratory diseases, " http://www . who. int/respiratory/copd/burden/en.
3. M. Bartal, "COPD, tobacco smoke, " Monaldi archives for chest disease, vol. 63, pp. 213-225, 2005.
4. Y. Chiba, M. Murata, H. Ushikubo, et al. , "Efect of cigarette smoke exposure in vivo on bronchial smooth muscle contractility in vitro in rats, " American Journal of Respiratory Cell, Molecular Biology, vol. 33, no. 6, pp. 574-581, 2005.
5. Z.-H. Chen, H. P. Kim, F. C. Sciurba, et al. , "Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease, " PLoS ONE, vol. 3, no. 10, Article ID e3316, 2008.
6. N. Soulitzis, E. Neofytou, M. Psarrou, et al. , "Downregulation of lung mitochondrial prohibitin in COPD, " Respiratory Medicine, vol. 106, no. 7, pp. 954-961, 2012.
7. S. H. van Rijt, I. E. Keller, G. John, et al. , "Acute cigarette smoke exposure impairs proteasome function in the lung, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 303, no. 9, pp. L814-L823, 2012.
8. A. Meyer, J. Zoll, A. L. Charles, et al. , "Skeletal muscle mito-chondrial dysfunction during chronic obstructive pulmonary disease: central actor, therapeutic target, " Experimental Physiology, vol. 98, no. 6, pp. 1063-1078, 2013.
9. J. L. Wright, A. Churg, "Cigarette smoke causes physiologic, morphologic changes of emphysema in the guinea pig, " American Review of Respiratory Disease, vol. 142, no. 6, pp. 1422-1428, 1990.
10. H. S. Sekhon, J. L. Wright, A. Churg, "Cigarette smoke causes rapid cell proliferation in small airways, associated pulmonary arteries, " American Journal of Physiology, vol. 267, no. 5, pp. L557-L563, 1994.
11. J. L. Wright, J.-P. Sun, "Efect of smoking cessation on pulmonary, cardiovascular function, structure: analysis of guinea pig model, " Journal of Applied Physiology, vol. 76, no. 5, pp. 2163-2168, 1994.
12. H. Yamato, J. P. Sun, A. Churg, J. L. Wright, "Guinea pig pulmonary hypertension caused by cigarette smoke cannot be explained by capillary bed destruction, " Journal of Applied Physiology, vol. 82, no. 5, pp. 1644-1653, 1997.
13. A. F. Ofulue, K. O. Mary, R. T. Abboud, "Time course of neutrophil, macrophage elastinolytic activities in cigarette smoke-induced emphysema, " American Journal of Physiology, vol. 275, no. 6, pp. L1134-L1144, 1998.
14. A. F. Ofulue, M. Ko, "Efects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 277, no. 1, pp. L97-L105, 1999.
15. J. L. Wright, J.-P. Sun, A. Churg, "Cigarette smoke exposure causes constriction of rat lung explant airways, " European Respiratory Journal, vol. 14, no. 5, pp. 1095-1099, 1999.
16. J. L. Wright, J.-P. Sun, "Dissociation of chronic vascular cell proliferation, vascular contractility afer chronic cigarette smoke exposure, " European Respiratory Journal, vol. 14, no. 4, pp. 832-838, 1999.
17. A. I. D'hulst, K. Y. Vermaelen, G. G. Brusselle, G. F. Joos, R. A. Pauwels, "Time course of cigarette smoke-induced pulmonary infammation in mice, " European Respiratory Journal, vol. 26, no. 2, pp. 204-213, 2005.
18. K. B. Moerloose, R. A. Pauwels, G. F. Joos, "Short-term cigarette smoke exposure enhances allergic airway infamma-tion in mice, " American Journal of Respiratory, Critical Care Medicine, vol. 172, no. 2, pp. 168-172, 2005.
19. B. W. A. van der Strate, D. S. Postma, C.-A. Brandsma, et al. , "Cigarette smoke-induced emphysema: a role for the B cell" American Journal of Respiratory, Critical Care Medicine, vol. 173, no. 7, pp. 751-758, 2006.
20. K. C. Hodge-Bell, K. M. Lee, R. A. Renne, K. M. Gideon, S. J. Harbo, W. J. McKinney, "Pulmonary infammation in mice exposed to mainstream cigarette smoke, " Inhalation Toxicology, vol. 19, no. 4, pp. 361-376, 2007.
21. T. Maeno, A. M. Houghton, P. A. Quintero, S. Grumelli, C. A. Owen, S. D. Shapiro, "CD8+ T cells are required for infammation, destruction in cigarette smoke-induced emphysema in mice, " Journal of Immunology, vol. 178, no. 12, pp. 8090-8096, 2007.
22. M.-J. Kang, G. L. Chun, J.-Y. Lee, et al. , "Cigarette smoke selectively enhances viral PAMP-, virus-induced pulmonary innate immune, remodeling responses in mice, " Journal of Clinical Investigation, vol. 118, no. 8, pp. 2771-2784, 2008.
23. C. C. J. Zavitz, G. J. Gaschler, C. S. Robbins, F. M. Botelho, P. G. Cox, M. R. Stampfi, "Impact of cigarette smoke on T, B cell responsiveness, " Cellular Immunology, vol. 253, no. 1-2, pp. 38-44, 2008.
24. A. Churg, S. Zhou, X. Wang, R. Wang, J. L. Wright, "Te role of interleukin-1beta in murine cigarette smoke-induced emphysema, small airway remodeling, " American Journal of Respiratory Cell, Molecular Biology, vol. 40, pp. 482-490, 2009.
25. J. J. Atkinson, B. A. Lutey, Y. Suzuki, et al. , "Te role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema, " American Journal of Respiratory, Critical Care Medicine, vol. 183, no. 7, pp. 876-884, 2011.
26. D. Doḿnguez-Fandos, V. I. Peinado, R. Puig-Pey, et al. , "Pulmonary infammatory reaction, structural changes induced by cigarette smoke exposure in the guinea pig, " COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 9, no. 5, pp. 473-484, 2012.
27. J. L. Wright, S. Zhou, A. Churg, "Pulmonary hypertension, vascular oxidative damage in cigarette smoke exposed eNOS-/-mice, human smokers, " Inhalation Toxicology, vol. 24, no. 11, pp. 732-740, 2012.
28. J. D. Escolar, M. N. Martnez, F. J. Rodŕguez, C. Gonzalo, M. A. Escolar, P. A. Roche, "Emphysema as a result of involuntary exposure to tobacco smoke: morphometrical study of the rat, " Experimental Lung Research, vol. 21, no. 2, pp. 255-273, 1995.
29. M. Selman, M. Montanõ, C. Ramos, et al. , "Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 271, no. 5, pp. L734-L743, 1996.
30. E. Cavarra, B. Bartalesi, M. Lucattelli, et al. , "Efects of cigarette smoke in mice with diferent levels of 1-proteinase inhibitor, sensitivity to oxidants, " American Journal of Respiratory, Critical Care Medicine, vol. 164, no. 5, pp. 886-890, 2001.
31. T. Rangasamy, C. Y. Cho, R. K. Timmulappa, et al. , "Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice, " Journal of Clinical Investigation, vol. 114, no. 9, pp. 1248-1259, 2004.
32. B. Bartalesi, E. Cavarra, S. Fineschi, et al. , "Diferent lung responses to cigarette smoke in two strains of mice sensitive to oxidants, " European Respiratory Journal, vol. 25, no. 1, pp. 15-22, 2005.
33. C. S. Stevenson, K. Coote, R. Webster, et al. , "Characterization of cigarette smoke-induced infammatory, mucus hyper-secretory changes in rat lung, the role of CXCR2 ligands in mediating this efect, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 288, no. 3, pp. L514-L522, 2005.
34. T. H. March, J. A. Wilder, D. C. Esparza, et al. , "Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice, " Toxicological Sciences, vol. 92, no. 2, pp. 545-559, 2006.
35. H. Yao, I. Edirisinghe, S. Rajendrasozhan, et al. , "Cigarette smoke-mediated infammatory, oxidative responses are strain-dependent in mice, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 294, no. 6, pp. L1174-L1186, 2008.
36. A. Morris, G. Kinnear, W.-Y. H. Wan, D. Wyss, P. Bahra, C. S. Stevenson, "Comparison of cigarette smoke-induced acute infammation in multiple strains of mice, the efect of a matrix metalloproteinase inhibitor on these responses, " Journal of Pharmacology, Experimental Terapeutics, vol. 327, no. 3, pp. 851-862, 2008.
37. P. Golovatch, B. A. Mercer, V. Lematre, A. Wallace, R. F. Foronjy, J. D'Armiento, "Role for cathepsin K in emphysema in smoke-exposed guinea pigs, " Experimental Lung Research, vol. 35, no. 8, pp. 631-645, 2009.
38. S. P. Rao, L. Sikora, M. R. Hosseinkhani, K. E. Pinker-ton, P. Sriramarao, "Exposure to environmental tobacco smoke induces angiogenesis, leukocyte trafcking in lung microvessels, " Experimental Lung Research, vol. 35, no. 2, pp. 119-135, 2009.
39. P. G. Woodruf, A. Ellwanger, M. Solon, C. J. Cambier, K. E. Pinkerton, L. L. Koth, "Alveolar macrophage recruitment, activation by chronic second hand smoke exposure in Mice, " COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 2, pp. 86-94, 2009.
40. F. M. Botelho, G. J. Gaschler, S. Kianpour, et al. , "Innate immune processes are sufcient for driving cigarette smoke-induced infammation in mice, " American Journal of Respiratory Cell, Molecular Biology, vol. 42, no. 4, pp. 394-403, 2010.
41. J. A. Marwick, I. Edirisinghe, G. Arunachalam, et al. , "Cigarette smoke regulates VEGFR2-mediated survival signaling in rat lungs, " Journal of Infammation, vol. 7, article 11, 2010.
42. G. T. Motz, B. L. Eppert, S. C. Wesselkamper, J. L. Flury, M. T. Borchers, "Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/-mice, " American Journal of Respiratory, Critical Care Medicine, vol. 181, no. 11, pp. 1223-1233, 2010.
43. S. Braber, P. J. Koelink, P. A. J. Henricks, et al. , "Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 300, no. 2, pp. L255-L265, 2011.
44. F. M. Botelho, C. M. T. Bauer, D. Finch, et al. , "IL-1/IL-1R1 expression in chronic obstructive pulmonary disease, mechanistic relevance to smoke-induced neutrophilia in mice, " PLoS ONE, vol. 6, no. 12, Article ID e28457, 2011.
45. B. B. Davis, J.-Y. Liu, D. J. Tancredi, et al. , "Te anti-infammatory efects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment, " Biochemical, Biophysical Research Communications, vol. 410, no. 3, pp. 494-500, 2011.
46. S. Eltom, C. S. Stevenson, J. Rastrick, et al. , "P2x7 receptor, caspase 1 activation are central to airway infammation observed afer exposure to tobacco smoke, " PLoS ONE, vol. 6, no. 9, Article ID e24097, 2011.
47. L. Farkas, D. Farkas, D. Warburton, et al. , "Cigarette smoke exposure aggravates air space enlargement, alveolar cell apoptosis in Smad3 knockout mice, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 301, no. 4, pp. L391-L401, 2011.
48. Y.-C. Nie, H. Wu, P.-B. Li, et al. , "Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease, " Pulmonary Pharmacology, Terapeutics, vol. 25, no. 5, pp. 349-356, 2012.
49. X. Zhao, D.-X. Bu, K. Hayfron, et al. , "A combination of secondhand cigarette smoke, Chlamydia pneumoniae accelerates atherosclerosis, " Atherosclerosis, vol. 222, no. 1, pp. 59-66, 2012.
50. B. L. Eppert, B. W. Wortham, J. L. Flury, M. T. Borchers, "Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease, " Journal of Immunology, vol. 190, no. 3, pp. 1331-1340, 2013.
51. A. Kratzer, J. Salys, C. Nold-Petry, et al. , "Role of IL-18 in second-hand smoke-induced emphysema, " American Journal of Respiratory Cell, Molecular Biology, vol. 48, no. 6, pp. 725-732, 2013
52. Erratum in American Journal of Respiratory Cell, Molecular Biology, vol. 50, no. 2, p. 470, 2014.
53. C. Fletcher, R. Peto, "Te natural history of chronic airfow obstruction, " British Medical Journal, vol. 1, no. 6077, pp. 1645-1648, 1977.
54. S.-F. Liu, H.-C. Kuo, C.-W. Tseng, et al. , "Leukocyte mitochon-drial DNA copy number is associated with chronic obstructive pulmonary disease, " PLoS ONE, vol. 10, no. 9, Article ID e0138716, 2015.
55. C. E. Behrendt, "Mild, moderate-to-severe COPD in non-smokers: distinct demographic profles, " Chest, vol. 128, no. 3, pp. 1239-1244, 2005.
56. B. R. Celli, R. J. Halbert, R. J. Nordyke, B. Schau, "Airway obstruction in never smokers: results from the Tird National Health, Nutrition Examination Survey, " Te American Journal of Medicine, vol. 118, no. 12, pp. 1364-1372, 2005.
57. B. Lamprecht, M. A. McBurnie, W. M. Vollmer, et al. , "COPD in never smokers: results from the population-based burden of obstructive lung disease study, " Chest, vol. 139, no. 4, pp. 752-763, 2011.
58. D. B. Hancock, M. Eijgelsheim, J. B. Wilk, et al. , "Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function, " Nature Genetics, vol. 42, no. 1, pp. 45-52, 2010.
59. S. G. Pillai, D. Ge, G. Zhu, et al. , "A genome-wide association study in chronic obstructive pulmonary disease (COPD): iden-tifcation of two major susceptibility loci, " PLoS Genetics, vol. 5, no. 3, Article ID e1000421, 2009.
60. J. B. Wilk, T.-H. Chen, D. J. Gottlieb, et al. , "A genome-wide association study of pulmonary function measures in the framingham heart study, " PLoS Genetics, vol. 5, no. 3, Article ID e1000429, 2009.
61. G. M. Hunninghake, M. H. Cho, Y. Tesfaigzi, et al. , "MMP12, lung function, COPD in high-risk populations, " Te New England Journal of Medicine, vol. 361, no. 27, pp. 2599-2608, 2009.
62. D. Lambrechts, I. Buysschaert, P. Zanen, et al. , "Te 15q24/25 susceptibility variant for lung cancer, chronic obstructive pulmonary disease is associated with emphysema, " American Journal of Respiratory, Critical Care Medicine, vol. 181, no. 5, pp. 486-493, 2010.
63. B. Zöller, X. Li, J. Sundquist, K. Sundquist, "Familial transmission of chronic obstructive pulmonary disease in adoptees: a Swedish nationwide family study, " BMJ Open, vol. 5, no. 4, Article ID e007310, 2015.
64. B. Aravamudan, M. A. Tompson, C. M. Pabelick, Y. S. Prakash, "Mitochondria in lung diseases, " Expert Review of Respiratory Medicine, vol. 7, no. 6, pp. 631-646, 2013.
65. J. E. Repine, A. Bast, I. Lankhorst, "Oxidative stress in chronic obstructive pulmonary disease, " American Journal of Respiratory, Critical Care Medicine, vol. 156, no. 2 I, pp. 341-357, 1997.
66. P. A. Kirkham, P. J. Barnes, "Oxidative stress in COPD, " Chest, vol. 144, no. 1, pp. 266-273, 2013.
67. R. Nielsen, A. Johannessen, B. Benediktsdottir, et al. , "Present, future costs of COPD in Iceland, Norway: results from the BOLD study, " European Respiratory Journal, vol. 34, no. 4, pp. 850-857, 2009.
68. P. J. Barnes, B. R. Celli, "Systemic manifestations, comorbidities of COPD, " European Respiratory Journal, vol. 33, no. 5, pp. 1165-1185, 2009.
69. P. W. Borosand, W. Lubiński, "Health state, the quality of life in patients with chronic obstructive pulmonary disease in Poland: a study using the EuroQoL-5D questionnaire, " Polskie Archiwum Medycyny Wewntrznej, vol. 122, no. 3, pp. 73-81, 2012.
70. J. Mikowska-Dymanowska, A. J. Biaas, A. Zalewska-Janowska, P . Górski, W. J. Piotrowski, "Underrecognized comorbidi-ties of chronic obstructive pulmonary disease, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 10, pp. 1331-1341, 2015.
71. R. A. Incalzi, L. Fuso, M. De Rosa, et al. , "Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease, " European Respiratory Journal, vol. 10, no. 12, pp. 2794-2800, 1997.
72. M. C. Smith, J. P. Wrobel, "Epidemiology, clinical impact of major comorbidities in patients with COPD, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 871-888, 2014.
73. A. Frei, P. Muggensturm, N. Putcha, et al. , "Five comorbidities refected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index, " Journal of Clinical Epidemiology, vol. 67, no. 8, pp. 904-911, 2014.
74. L. E. G. W. Vanfeteren, M. A. Spruit, M. Groenen, et al. , "Clusters of comorbidities based on validated objective measurements, systemic infammation in patients with chronic obstructive pulmonary disease, " American Journal of Respiratory, Critical Care Medicine, vol. 187, no. 7, pp. 728-735, 2013.
75. N. J. Roberts, S. J. Lloyd-Owen, F. Rapado, et al. , "Relationship between chronic nasal, respiratory symptoms in patients with COPD, " Respiratory Medicine, vol. 97, no. 8, pp. 909-914, 2003.
76. G. Hens, B. M. Vanaudenaerde, D. M. A. Bullens, et al. , "Sinonasal pathology in nonallergic asthma, COPD: 'united airway disease' beyond the scope of allergy, " Allergy: European Journal of Allergy, Clinical Immunology, vol. 63, no. 3, pp. 261-267, 2008.
77. A. Kelemence, O. Abadoglu, C. Gumus, S. Berk, K. Epozturk, I. Akkurt, "Te frequency of chronic rhinosinusitis/nasal polyp in COPD, its efect on the severity of COPD, " Journal of Chronic Obstructive Pulmonary Disease, vol. 8, no. 1, pp. 8-12, 2011.
78. M. Divo, C. Cote, J. P. de Torres, et al. , "Comorbidities, risk of mortality in patients with chronic obstructive pulmonary disease, " American Journal of Respiratory, Critical Care Medicine, vol. 186, no. 2, pp. 155-161, 2012.
79. C. H. Martinez, Y. Okajima, S. Murray, et al. , "Impact of self-reported Gastroesophageal refux disease in subjects from COPDGene cohort, " Respiratory Research, vol. 15, no. 1, article no. 62, 2014.
80. M. Miyazaki, H. Nakamura, S. Chubachi, et al. , "Analysis of comorbid factors that increase the COPD assessment test scores, " Respiratory Research, vol. 15, no. 1, article no. 13, 2014.
81. M. Ajmera, A. D. Raval, C. Shen, U. Sambamoorthi, "Explaining the increased health care expenditures associated with gastroesophageal refux disease among elderly Medicare benefciaries with chronic obstructive pulmonary disease: a cost-decomposition analysis, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 339-348, 2014.
82. K. Terada, S. Muro, S. Sato, et al. , "Impact of gastro-oesophageal refux disease symptoms on COPD exacerbation, " Torax, vol. 63, no. 11, pp. 951-955, 2008.
83. J. Kim, J. H. Lee, Y. Kim, et al. , "Association between chronic obstructive pulmonary disease, gastroesophageal refux disease: A National Cross-Sectional Cohort Study, " BMC Pulmonary Medicine, vol. 13, no. 1, article no. 51, 2013.
84. G. T. Ferguson, P. M. A. Calverley, J. A. Anderson, et al. , "Prevalence, progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study, " Chest, vol. 136, no. 6, pp. 1456-1465, 2009.
85. S. M. Curkendall, C. DeLuise, J. K. Jones, et al. , "Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients, " Annals of Epidemiology, vol. 16, no. 1, pp. 63-70, 2006.
86. C. A. Keller, J. W. Shepard Jr. , D. S. Chun, P. Vasquez, G. F. Dolan, "Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis, " Chest, vol. 90, no. 2, pp. 185-192, 1986.
87. J. Finkelstein, E. Cha, S. M. Scharf, "Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 4, pp. 337-349, 2009.
88. G. Gudmundsson, T. Gislason, C. Janson, et al. , "Depression, anxiety, health status afer hospitalisation for COPD: a mul-ticentre study in the Nordic countries, " Respiratory Medicine, vol. 100, no. 1, pp. 87-93, 2006.
89. N. A. Hanania, H. Müllerova, N. W. Locantore, et al. , "Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort, " American Journal of Respiratory, Critical Care Medicine, vol. 183, no. 5, pp. 604-611, 2011.
90. D. W. Mapel, M. A. Picchi, J. S. Hurley, et al. , "Utilization in COPD: patient characteristics, diagnostic evaluation, " Chest, vol. 117, no. 5, supplement 2, pp. 346S-353S, 2000.
91. K. Kühl, W. Schürmann, W. Rief, "Mental disorders, quality of life in COPD patients, their spouses, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 3, no. 4, pp. 727-736, 2008.
92. H. M. McBride, M. Neuspiel, S. Wasiak, "Mitochondria: more than just a powerhouse, " Current Biology, vol. 16, no. 14, pp. R551-R560, 2006.
93. M. F. Rossier, "T channels, steroid biosynthesis: in search of a link with mitochondria, " Cell Calcium, vol. 40, no. 2, pp. 155-164, 2006.
94. D. R. Green, "Apoptic pathways: the roads to ruin, " Cell, vol. 94, no. 6, pp. 695-698, 1998.
95. N. Camougrand, M. Rigoulet, "Aging, oxidative stress: studies of some genes involved both in aging, in response to oxidative stress, " Respiration Physiology, vol. 128, no. 3, pp. 393-401, 2001.
96. E. Mills, L. A. J. O'Neill, "Succinate: a metabolic signal in infammation, " Tre n d s in Cel l Biol o g y , vol. 24, no. 5, pp. 313-320, 2014.
97. D. Canbaz, A. Logiantara, T. Hamers, R. Van Ree, L. S. Van Rijt, "Indoor pollutant hexabromocyclododecane has a modest immunomodulatory efect on house dust mite induced allergic asthma in mice, " Environmental Science, Technology, vol. 50, no. 1, pp. 405-411, 2016.
98. A. Bacsi, L. Pan, X. Ba, I. Boldogh, "Pathophysiology of bronchoconstriction: role of oxidatively damaged DNA repair, " Current Opinion in Allergy, Clinical Immunology, vol. 16, no. 1, pp. 59-67, 2016.
99. A. M. Cantin, M. V. Richter, "Cigarette smoke-induced proteostasis imbalance in obstructive lung diseases, " Current Molecular Medicine, vol. 12, no. 7, pp. 836-849, 2012.
100. S. A. Meo, F. Suraya, "Efect of environmental air pollution on cardiovascular diseases, " European Review for Medical, Pharmacological Sciences, vol. 19, pp. 4890-4897, 2015.
101. A. Valavanidis, T. Vlachogianni, K. Fiotakis, "Tobacco smoke: involvement of reactive oxygen species, stable free radicals in mechanisms of oxidative damage, carcinogenesis, synergistic efects with other respirable particles, " International Journal of Environmental Research, Public Health, vol. 6, no. 2, pp. 445-462, 2009.
102. M. van der Toorn, D. Rezayat, H. F. Kaufman, et al. , "Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 297, no. 1, pp. L109-L114, 2009.
103. A. M. Cantin, G. A. Fells, R. C. Hubbard, R. G. Crystal, "Antioxidant macromolecules in the epithelial lining fuid of the normal human lower respiratory tract, " Te Journal of Clinical Investigation, vol. 86, no. 3, pp. 962-971, 1990.
104. V. N. Bochkov, O. V. Oskolkova, K. G. Birukov, A.-L. Levonen, C. J. Binder, J. Stöckl, "Generation, biological activities of oxidized phospholipids, " Antioxidants & Redox Signaling, vol. 12, no. 8, pp. 1009-1059, 2010.
105. Y. Imai, K. Kuba, G. G. Neely, et al. , "Identifcation of oxidative stress, Toll-like receptor 4 signaling as a key pathway of acute lung injury, " Cell, vol. 133, no. 2, pp. 235-249, 2008.
106. S. Rajendrasozhan, S.-R. Yang, I. Edirisinghe, H. Yao, D. Ade-nuga, I. Rahman, "Deacetylases, NF-B in redox regulation of cigarette smoke-induced lung infammation: epigenetics in pathogenesis of COPD, " Antioxidants & Redox Signaling, vol. 10, no. 4, pp. 799-811, 2008.
107. S. Ghosh, M. Karin, "Missing pieces in the NF-B puzzle, " Cell, vol. 109, no. 2, pp. S81-S96, 2002.
108. M. Schuliga, "NF-B signaling in chronic infammatory airway disease, " Biomolecules, vol. 5, no. 3, pp. 1266-1283, 2015.
109. I. Rahman, J. Marwick, P. Kirkham, "Redox modulation of chromatin remodeling: impact on histone acetylation, deacetylation, NF-B, pro-infammatory gene expression, " Biochemical Pharmacology, vol. 68, no. 6, pp. 1255-1267, 2004.
110. A. Di Stefano, G. Caramori, T. Oates, et al. , "Increased expression of nuclear factor-B in bronchial biopsies from smokers, patients with COPD, " European Respiratory Journal, vol. 20, no. 3, pp. 556-563, 2002.
111. B. P. Ashburner, S. D. Westerheide, A. S. Baldwin Jr. , "Te p65 (RelA) subunit of NF-B interacts with the histone deacetylase (HDAC) corepressors HDAC1, HDAC2 to negatively regulate gene expression, " Molecular, Cellular Biology, vol. 21, no. 20, pp. 7065-7077, 2001.
112. S. Rajendrasozhan, H. Yao, I. Rahman, "Current perspectives on role of chromatin modifcations, deacetylases in lung infammation in COPD, " COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 4, pp. 291-297, 2009.
113. N. Sengupta, E. Seto, "Regulation of histone deacetylase activities, " Journal of Cellular Biochemistry, vol. 93, no. 1, pp. 57-67, 2004.
114. K. Ito, M. Ito, W. M. Elliott, et al. , "Decreased histone deacetylase activity in chronic obstructive pulmonary disease, " New England Journal of Medicine, vol. 352, no. 19, pp. 1967-1976, 2005.
115. K. Ito, P. J. Barnes, I. M. Adcock, "Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1-induced histone H4 acetylation on lysines 8, 12, " Molecular, Cellular Biology, vol. 20, no. 18, pp. 6891-6903, 2000.
116. M. Kobayashi, M. Yamamoto, "Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles, reactive oxygen species, " Advances in Enzyme Regulation, vol. 46, no. 1, pp. 113-140, 2006.
117. U. Oltmanns, K. F. Chung, M. Walters, M. John, J. A. Mitchell, "Cigarette smoke induces IL-8, but inhibits eotaxin, RANTES release from airway smooth muscle, " Respiratory Research, vol. 6, article no. 74, 2005.
118. J. C. Hedges, C. A. Singer, W. T. Gerthofer, "Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes, " American Journal of Respiratory Cell, Molecular Biology, vol. 23, no. 1, pp. 86-94, 2000.
119. S. McKay, S. J. Hirst, M. Bertrand-De Haas, et al. , "Tumor necrosis factor-enhances mRNA expression, secretion of interleukin-6 in cultured human airway smooth muscle cells, " American Journal of Respiratory Cell, Molecular Biology, vol. 23, no. 1, pp. 103-111, 2000.
120. R. Issa, S. Xie, K.-Y. Lee, et al. , "GRO-regulation in airway smooth muscle by IL-1, TNF-: role of NF-B, MAP kinases, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 291, no. 1, pp. L66-L74, 2006.
121. J. L. Pype, L. J. Dupont, P. Menten, et al. , "Expression of monocyte chemotactic protein (MCP)-1, MCP-2, MCP-3 by human airway smooth-muscle cells: modulation by cor-ticosteroids, T-helper 2 cytokines, " American Journal of Respiratory Cell, Molecular Biology, vol. 21, no. 4, pp. 528-536, 1999.
122. M. C. Catley, M. B. Sukkar, K. F. Chung, et al. , "Validation of the anti-infammatory properties of small-molecule IB kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1, IKK2 in human airways smooth muscle, " Molecular Pharmacology, vol. 70, no. 2, pp. 697-705, 2006.
123. D. S. Fafe, T. Whitehead, P. E. Moore, et al. , "IL-13, IL-4 promote TARC release in human airway smooth muscle cells: role of IL-4 receptor genotype, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 285, no. 4, pp. L907-L914, 2003.
124. K. Zhang, L. Shan, M. S. Rahman, H. Unruh, A. J. Halayko, A. S. Gounni, "Constitutive, inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 293, no. 2, pp. L375-L382, 2007.
125. A. Sauty, M. Dziejman, R. A. Taha, et al. , "Te T cell-specifc CXC chemokines IP-10, Mig, I-TAC are expressed by activated human bronchial epithelial cells, " Journal of Immunology, vol. 162, no. 6, pp. 3549-3558, 1999.
126. E. L. Hardaker, A. M. Bacon, K. Carlson, et al. , "Regulation of TNF-alpha-, IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary infammatory response in chronic obstructive pulmonary disease, " Te FASEB Journal, vol. 18, no. 1, pp. 191-193, 2004.
127. D. V. Pechkovsky, T. Goldmann, C. Ludwig, et al. , "CCR2, CXCR3 agonistic chemokines are diferently expressed, regulated in human alveolar epithelial cells type II, " Respiratory Research, vol. 6, article no. 75, 2005.
128. S. J. Tudhope, M. C. Catley, P. S. Fenwick, et al. , "Te role of IB kinase 2, but not activation of NF-B, in the release of CXCR3 ligands from IFN-stimulated human bronchial epithelial cells, " Te Journal of Immunology, vol. 179, no. 9, pp. 6237-6245, 2007.
129. D. L. Clarke, R. L. Cliford, S. Jindarat, et al. , "TNF, IFN synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-B, the transcriptional coactivator CREB-binding protein, " Journal of Biological Chemistry, vol. 285, no. 38, pp. 29101-29110, 2010.
130. P. J. Barnes, "Te cytokine network in chronic obstructive pulmonary disease, " American Journal of Respiratory Cell, Molecular Biology, vol. 41, no. 6, pp. 631-638, 2009.
131. C. J. Baglole, P. J. Sime, R. P. Phipps, "Cigarette smoke-induced expression of heme oxygenase-1 in human lung fbrob-lasts is regulated by intracellular glutathione, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 295, no. 4, pp. L624-L636, 2008.
132. H. Boström, K. Willetts, M. Pekny, et al. , "PDGF-A signaling is a critical event in lung alveolar myofbroblast development, alveogenesis, " Cell, vol. 85, no. 6, pp. 863-873, 1996.
133. G. Deslee, T. L. Adair-Kirk, T. Betsuyaku, et al. , "Cigarette smoke induces nucleic-acid oxidation in lung fbroblasts, " American Journal of Respiratory Cell, Molecular Biology, vol. 43, no. 5, pp. 576-584, 2010.
134. C. A. Martey, S. J. Pollock, C. K. Turner, et al. , "Cigarette smoke induces cyclooxygenase-2, microsomal prostaglandin E2 synthase in human lung fbroblasts: implications for lung infammation, cancer, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 287, no. 5, pp. L981-L991, 2004.
135. T. Yoshida, I. Mett, A. K. Bhunia, et al. , "Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury, emphysema, " Nature Medicine, vol. 16, no. 7, pp. 767-773, 2010.
136. M. M. Shi, J. J. Godleski, J. D. Paulauskis, "Regulation of macrophage infammatory protein-1 mRNA by oxidative stress, " Journal of Biological Chemistry, vol. 271, no. 10, pp. 5878-5883, 1996.
137. R. M. Tuder, L. Zhen, C. Y. Cho, et al. , "Oxidative stress, apoptosis interact, cause emphysema due to vascular endothelial growth factor receptor blockade, " American Journal of Respiratory Cell, Molecular Biology, vol. 29, no. 1, pp. 88-97, 2003.
138. S. L. Kunkel, T. Standiford, K. Kasahara, R. M. Strieter, "Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung, " Experimental Lung Research, vol. 17, no. 1, pp. 17-23, 1991.
139. M. Leberl, A. Kratzer, L. Taraseviciene-Stewart, "Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page" Frontiers in Physiology, vol. 4, article 91, 2013.
140. G. Sawicki, "Intracellular regulation of matrix metalloprotein-ase-2 activity: new strategies in treatment, protection of heart subjected to oxidative stress, " Scientifca, vol. 2013, Article ID 130451, 12 pages, 2013.
141. E. Hasnis, M. Bar-Shai, Z. Burbea, A. Z. Reznick, "Mechanisms underlying cigarette smoke-induced NF-B activation in human lymphocytes: the role of reactive nitrogen species, " Journal of Physiology, Pharmacology, vol. 58, no. S5, pp. 275-287, 2007.
142. L. DeMaio, M. Rouhanizadeh, S. Reddy, A. Sevanian, J. Hwang, T. K. Hsiai, "Oxidized phospholipids mediate occludin expression, phosphorylation in vascular endothelial cells, " American Journal of Physiology-Heart, Circulatory Physiology, vol. 290, no. 2, pp. H674-H683, 2006.
143. M. Rouhanizadeh, J. Hwang, R. E. Clempus, et al. , "Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase, " Free Radical Biology, Medicine, vol. 39, no. 11, pp. 1512-1522, 2005.
144. D. Li, D. Chen, X. Zhang, et al. , "c-Jun N-terminal kinase, Akt signalling pathways regulating tumour necrosis factor-induced interleukin-32 expression in human lung fbroblasts: implications in airway infammation, " Immunology, vol. 144, no. 2, pp. 282-290, 2015.
145. A. Bowie, L. A. J. O'Neill, "Oxidative stress, nuclear factor-B activation: a reassessment of the evidence in the light of recent discoveries, " Biochemical Pharmacology, vol. 59, no. 1, pp. 13-23, 2000.
146. A. L. Lazaar, Y. Amrani, J. Hsu, et al. , "CD40-mediated signal transduction in human airway smooth muscle, " Journal of Immunology, vol. 161, no. 6, pp. 3120-3127, 1998.
147. I. M. Adcock, C. R. Brown, H. Shirasaki, P. J. Barnes, "Efects of dexamethasone on cytokine, phorbol ester stimulated c-Fos, c-Jun DNA binding, gene expression in human lung, " European Respiratory Journal, vol. 7, no. 12, pp. 2117-2123, 1994.
148. A. J. Templeton, O. Ace, M. G. McNamara, et al. , "Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review, meta-analysis, " Cancer Epidemiology Biomarkers, Prevention, vol. 23, no. 7, pp. 1204-1212, 2014.
149. Y. Ohsugi, "Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated infammatory diseases, " Biological, Pharmaceutical Bulletin, vol. 30, no. 11, pp. 2001-2006, 2007.
150. T. Imai, K. Koike, T. Kubo, et al. , "Interleukin-6 supports human megakaryocytic proliferation, diferentiation in vitro, " Blood, vol. 78, no. 8, pp. 1969-1974, 1991.
151. B. E. Lippitz, "Cytokine patterns in patients with cancer: a systematic review, " Te Lancet Oncology, vol. 14, no. 6, pp. e218-e228, 2013.
152. M. H. F. Klinger, W. Jelkmann, "Role of blood platelets in infection, infammation, " Journal of Interferon, Cytokine Research, vol. 22, no. 9, pp. 913-922, 2002.
153. H. M. Nording, P. Seizer, H. F. Langer, "Platelets in infammation, atherogenesis, " Frontiers in Immunology, vol. 6, article no. 98, 2015.
154. T. Seno, N. Inoue, D. Gao, et al. , "Involvement of NADH/NADPH oxidase in human platelet ROS production, " Trombosis Research, vol. 103, no. 5, pp. 399-409, 2001.
155. R. Carnevale, P. Pignatelli, L. Lenti, et al. , "LDL are oxidatively modifed by platelets via GP91i °x, accumulate in human monocytes, " Te FASEB Journal, vol. 21, no. 3, pp. 927-934, 2007.
156. F. Calabrese, S. Baraldo, E. Bazzan, et al. , "IL-32, a novel proinfammatory cytokine in chronic obstructive pulmonary disease, " American Journal of Respiratory, Critical Care Medicine, vol. 178, no. 9, pp. 894-901, 2008.
157. S.-H. Kim, S.-Y. Han, T. Azam, D.-Y. Yoon, C. A. Dinarello, "Interleukin-32: a cytokine, inducer of TNFa, " Immunity, vol. 22, no. 1, pp. 131-142, 2005.
158. L. A. B. Joosten, B. Heinhuis, M. G. Netea, C. A. Dinarello, "Novel insights into the biology of interleukin-32, " Cellular, Molecular Life Sciences, vol. 70, no. 20, pp. 3883-3892, 2013.
159. M. Peters-Golden, W. R. Henderson Jr. , "Leukotrienes, " Te New England Journal of Medicine, vol. 357, pp. 1841-1854, 2007
160. M. Peters-Golden, "Expanding roles for leukotrienes in airway infammation, " Current Allergy, Asthma Reports, vol. 8, no. 4, pp. 367-373, 2008.
161. S. Batra, S. Cai, G Balamayooran, S. Jeyaseelan, "Intrapul-monary administration of leukotriene B4 augments neutrophil accumulation, responses in the lung to Klebsiella infection in CXCL1 knockout mice, " Te Journal of Immunology, vol. 188, no. 7, pp. 3458-3468, 2012.
162. S. L. Deshmane, S. Kremlev, S. Amini, B. E. Sawaya, "Monocyte chemoattractant protein-1 (MCP-1): an overview, " Journal of Interferon, Cytokine Research, vol. 29, no. 6, pp. 313-325, 2009.
163. I.-C. Lo, J.-M. Shih, M. J. Jiang, "Reactive oxygen species, ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration, " Journal of Biomedical Science, vol. 12, no. 2, pp. 377-388, 2005.
164. C. A. Owen, "Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease, " International Journal of Chronic Obstructive Pulmonary Disease, vol. 3, no. 2, pp. 253-268, 2008.
165. G. Droga-Mazovec, L. Bojic, A. Petelin, et al. , "Cysteine cathep-sins trigger caspase-dependent cell death through cleavage of bid, antiapoptotic Bcl-2 homologues, " Journal of Biological Chemistry, vol. 283, no. 27, pp. 19140-19150, 2008.
166. M. Padrines, M. Wolf, A. Walz, M. Baggiolini, "Interleukin-8 processing by neutrophil elastase, cathepsin G, proteinase-3, " FEBS Letters, vol. 352, no. 2, pp. 231-235, 1994.
167. U. Meyer-Hofert, "Neutrophil-derived serine proteases modulate innate immune responses, " Frontiers in Bioscience, vol. 14, no. 9, pp. 3409-3418, 2009.
168. A. Brehm, P. Geraghty, M. Campos, et al. , "Cathepsin G degradation of phospholipid transfer protein (PLTP) augments pulmonary infammation, " FASEB Journal, vol. 28, no. 5, pp. 2318-2331, 2014.
169. T. E. Taylor-Clark, "Role of reactive oxygen species, TRP channels in the cough refex, " Cell Calcium, vol. 60, no. 3, pp. 155-162, 2016.
170. Y. Liu, G. Fiskum, D. Schubert, "Generation of reactive oxygen species by the mitochondrial electron transport chain, " Journal of Neurochemistry, vol. 80, no. 5, pp. 780-787, 2002.
171. A. Boveris, B. Chance, "Te mitochondrial generation of hydrogen peroxide. General properties, efect of hyperbaric oxygen, " Biochemical Journal, vol. 134, no. 3, pp. 707-716, 1973.
172. Y. Chen, E. McMillan-Ward, J. Kong, S. J. Israels, S. B. Gibson, "Mitochondrial electron-transport-chain inhibitors of complexes I, II induce autophagic cell death mediated by reactive oxygen species, " Journal of Cell Science, vol. 120, no. 23, pp. 4155-4166, 2007.
173. Ò . Miró, J. R. Alonso, D. Jarreta, J. Casademont, Á. Urbano-Márquez, F. Cardellach, "Smoking disturbs mitochondrial respiratory chain function, enhances lipid peroxidation on human circulating lymphocytes, " Carcinogenesis, vol. 20, no. 7, pp. 1331-1336, 1999.
174. H.-Z. Zhou, X. Ma, M. O. Gray, et al. , "Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction, " Biochemical, Biophysical Research Communications, vol. 358, no. 1, pp. 189-195, 2007.
175. B. Menon, M. Singh, R. S. Ross, J. N. Johnson, K. Singh, "-Adrenergic receptor-stimulated apoptosis in adult cardiac myocytes involves MMP-2-mediated disruption of 1 integrin signaling, mitochondrial pathway, " American Journal of Physiology-Cell Physiology, vol. 290, no. 1, pp. C254-C261, 2006.
176. J. M. Santos, S. Tewari, J. Y. Lin, R. A. Kowluru, "Interrelationship between activation of matrix metalloproteinases, mitochondrial dysfunction in the development of diabetic retinopathy, " Biochemical, Biophysical Research Communications, vol. 438, no. 4, pp. 760-764, 2013.
177. X. Zhang, P. Shan, R. Homer, et al. , "Cathepsin E promotes pulmonary emphysema via mitochondrial fssion, " American Journal of Pathology, vol. 184, no. 10, pp. 2730-2741, 2014.
178. Z. Tang, A. T. Baykal, H. Gao, et al. , "mTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigation, " Journal of Proteome Research, vol. 13, no. 5, pp. 2433-2444, 2014.
179. A. Bononi, C. Agnoletto, E. De Marchi, et al. , "Protein kinases, phosphatases in the control of cell fate, " Enzyme Research, vol. 2011, Article ID 329098, 26 pages, 2011.
180. J. O. Lipton, M. Sahin, "Te Neurology of mTOR, " Neuron, vol. 84, no. 2, pp. 275-291, 2014.
181. C.-M. Hung, L. Garcia-Haro, C. A. Sparks, D. A. Guertin, "mTOR-dependent cell survival mechanisms, " Cold Spring Harbor Perspectives in Biology, vol. 4, no. 12, 2012.
182. K. Huang, D. C. Fingar, "Growing knowledge of the mTOR signaling network, " Seminars in Cell, Developmental Biology, vol. 36, pp. 79-90, 2014.
183. M. A. Hayat, Ed. , Autophagy: Cancer, Other Pathologies, Infam-mation, Immunity, Infection, Aging, vol. 4, 2014.
184. D. C. Chan, "Mitochondrial fusion, fssion in mammals, " Annual Review of Cell, Developmental Biology, vol. 22, pp. 79-99, 2006.
185. L. C. Gomes, G. D. Benedetto, L. Scorrano, "During auto-phagy mitochondria elongate, are spared from degradation, sustain cell viability, " Nature Cell Biology, vol. 13, no. 5, pp. 589-598, 2011.
186. Y.-S. Yoon, D.-S. Yoon, I. K. Lim, et al. , "Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1, " Journal of Cellular Physiology, vol. 209, no. 2, pp. 468-480, 2006.
187. V. Conti, G. Corbi, V. Manzo, G. Pelaia, A. Filippelli, A. Vatrella, "Sirtuin 1, aging theory for chronic obstructive pulmonary disease, " Analytical Cellular Pathology, vol. 2015, Article ID 897327, 8 pages, 2015.
188. J. Sauleda, F. Garcia-Palmer, R. J. Wiesner, et al. , "Cytochrome oxidase activity, mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease, " American Journal of Respiratory, Critical Care Medicine, vol. 157, no. 5 I, pp. 1413-1417, 1998.
189. L. Puente-Maestu, J. Pérez-Parra, R. Godoy, et al. , "Abnormal mitochondrial function in locomotor, respiratory muscles of COPD patients, " European Respiratory Journal, vol. 33, no. 5, pp. 1045-1052, 2009.
190. L. Puente-Maestu, J. Pérez-Parra, R. Godoy, et al. , "Abnormal transition pore kinetics, cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease, " American Journal of Respiratory Cell, Molecular Biology, vol. 40, no. 6, pp. 746-750, 2009.
191. L. Puente-Maestu, A. Tejedor, A. Lázaro, et al. , "Site of mito-chondrial reactive oxygen species production in skeletal muscle of chronic obstructive pulmonary disease, its relationship with exercise oxidative stress, " American Journal of Respiratory Cell, Molecular Biology, vol. 47, no. 3, pp. 358-362, 2012.
192. T. Harju, R. Kaarteenaho-Wiik, Y. Soini, R. Sormunen, V. L. Kinnula, "Diminished immunoreactivity of-glutamylcysteine synthetase in the airways of smokers' lung, " American Journal of Respiratory, Critical Care Medicine, vol. 166, no. 5, pp. 754-759, 2002.
193. M. Tomaki, H. Sugiura, A. Koarai, et al. , "Decreased expression of antioxidant enzymes, increased expression of chemokines in COPD lung, " Pulmonary Pharmacology, Terapeutics, vol. 20, no. 5, pp. 596-605, 2007.
194. A. R. De Souza, M. Zago, S. J. Pollock, P. J. Sime, R. P. Phipps, C. J. Baglole, "Genetic ablation of the aryl hydrocarbon receptor causes cigarette smoke-induced mitochondrial dysfunction, apoptosis, " Journal of Biological Chemistry, vol. 286, no. 50, pp. 43214-43228, 2011.
195. C. Michaeloudes, M. B. Sukkar, N. M. Khorasani, P. K. Bhavsar, K. F. Chung, "TGF-regulates Nox4, MnSOD, catalase expression, IL-6 release in airway smooth muscle cells, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 300, no. 2, pp. L295-L304, 2011.
196. J.-W. Hwang, S. Rajendrasozhan, H. Yao, et al. , "FOXO3 def-ciency leads to increased susceptibility to cigarette smoke-induced infammation, airspace enlargement, chronic obstructive pulmonary disease, " Journal of Immunology, vol. 187, no. 2, pp. 987-998, 2011.
197. N. Mercado, R. Timmulappa, C. M. R. Tomas, et al. , "Decreased histone deacetylase 2 impairs Nrf2 activation by oxida-tive stress, " Biochemical, Biophysical Research Communications, vol. 406, no. 2, pp. 292-298, 2011.
198. C. J. Baglole, S. B. Maggirwar, T. A. Gasiewicz, T. H. Tatcher, R. P. Phipps, P. J. Sime, "Te aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2, prostaglandin production in lung fbroblasts through regulation of the NF-B family member RelB, " Journal of Biological Chemistry, vol. 283, no. 43, pp. 28944-28957, 2008.
199. B. I. Frohnert, D. A. Bernlohr, "Protein carbonylation, mitochondrial dysfunction, insulin resistance, " Advances in Nutrition, vol. 4, no. 2, pp. 157-163, 2013.
200. Y. J. Suzuki, M. Carini, D. A. Butterfeld, "Protein carbony-lation, " Antioxidants, Redox Signaling, vol. 12, no. 3, pp. 323-325, 2010.
201. E. Barreiro, J. Gea, J. M. Corominas, S. N. A. Hussain, "Nitric oxide synthases, protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease, " American Journal of Respiratory Cell, Molecular Biology, vol. 29, no. 6, pp. 771-778, 2003.
202. Z. Kluchová, D. Petrásová, P. Joppa, Z. Dorková, R. Tkácová, "Te association between oxidative stress, obstructive lung impairment in patients with COPD, " Physiological Research, vol. 56, no. 1, pp. 51-56, 2007.
203. S. N. A. Hussain, G. Matar, E. Barreiro, M. Florian, M. Divangahi, T. Vassilakopoulos, "Modifcations of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats, " American Journal of Physiology-Lung Cellular, Molecular Physiology, vol. 290, no. 5, pp. L996-L1003, 2006.
204. S. Yavuzer, H. Yavuzer, M. Cengiz, et al. , "Te role of protein oxidation, DNA damage in elderly hypertension, " Aging Clinical, Experimental Research, vol. 28, no. 4, pp. 625-632, 2015.
205. M. Tanito, H. Nakamura, Y.-W. Kwon, et al. , "Enhanced oxidative stress, impaired thioredoxin expression in spontaneously hypertensive rats, " Antioxidants, Redox Signaling, vol. 6, no. 1, pp. 89-97, 2004.
206. A. Hoshino, Y. Okawa, M. Ariyoshi, et al. , "Oxidative post-translational modifcations develop LONP1 dysfunction in pressure overload heart failure, " Circulation: Heart Failure, vol. 7, no. 3, pp. 500-509, 2014.
207. D. Steinberg, "Low density lipoprotein oxidation, its patho-biological signifcance, " Journal of Biological Chemistry, vol. 272, no. 34, pp. 20963-20966, 1997.
208. Y.-J. Xu, M. Qiang, J.-L. Zhang, Y. Liu, R.-Q. He, "Reactive carbonyl compounds (RCCs) cause aggregation, dysfunction of fbrinogen, " Protein, Cell, vol. 3, no. 8, pp. 627-640, 2012.
209. L. Emelyanova, Z. Ashary, M. Cosic, et al. , "Selective downreg-ulation of mitochondrial electron transport chain activity, increased oxidative stress in human atrial fbrillation, " American Journal of Physiology-Heart, Circulatory Physiology, vol. 311, no. 1, pp. H54-H63, 2016.
210. E. Hopps, B. Canino, V. Calandrino, M. Montana, R. Lo Presti, G. Caimi, "Lipid peroxidation, protein oxidation are related to the severity of OSAS, " European Review for Medical, Pharmacological Sciences, vol. 18, no. 24, pp. 3773-3778, 2014.
211. H. M. Semchyshyn, "Reactive carbonyl species in vivo: generation, dual biological efects, " Te Scientifc World Journal, vol. 2014, Article ID 417842, 10 pages, 2014.
212. A. Gugliucci, "Glycation as the glucose link to diabetic complications, " Journal of the American Osteopathic Association, vol. 100, no. 10, pp. 621-634, 2000.
213. K. Uchida, "Role of reactive aldehyde in cardiovascular diseases, " Free Radical Biology, Medicine, vol. 28, no. 12, pp. 1685-1696, 2000.
214. P. A. Grimsrud, M. J. Picklo Sr. , T. J. Grifn, D. A. Ber-nlohr, "Carbonylation of adipose proteins in obesity, insulin resistance: identifcation of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal, " Molecular, Cellular Proteomics, vol. 6, no. 4, pp. 624-637, 2007.
215. S. Furukawa, T. Fujita, M. Shimabukuro, et al. , "Increased oxida-tive stress in obesity, its impact on metabolic syndrome, " Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752-1761, 2004.
216. S. Marsili, R. I. Salganik, C. D. Albright, et al. , "Cataract formation in a strain of rats selected for high oxidative stress, " Experimental Eye Research, vol. 79, no. 5, pp. 595-612, 2004.